帕金森病中痴呆的风险:系统审查和元分析
Lucy L Gibson1, Daniel Weintraub2,3, Roos Lemmen1
1Centre for Healthy Brain Ageing, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, UK.
概括
在帕金森病 (PD) 中,痴呆的年风险为4.5%,PD患者的风险比健康对照人高三倍以上. 研究变化与患者年龄,招募年份和地点有关.
科学领域:
- 神经学 神经学
- 流行病学 流行病学
- 老年病的医生 老年病的医生
背景情况:
- 在帕金森病 (PDD) 中对痴呆风险的估计显示出显著的变化.
- 了解PDD的发病率和风险因素对于患者护理和研究至关重要.
研究的目的:
- 系统地审查和分析帕金森病 (PDD) 中痴呆的发病率和相对风险.
- 识别导致研究中PDD风险估计异质性的因素.
主要方法:
- 按照PRISMA指南进行系统审查,搜索MEDLINE和EMBASE.
- 32项已识别的研究的元分析和元回归,包括25项关于PDD发病率和10项关于相对风险与健康对照 (HC) 的研究.
- 纳入标准要求进行纵向随访,在基线时至少有100名PD患者没有痴呆症.
主要成果:
- 总的每年PDD发病率为每100人/年4.45,表明每年4.5%的风险.
- 与HC相比,患有PD的人患痴呆症的相对风险是3.25倍.
- 研究异质性与患者年龄,招募年份和地理位置有关.
结论:
- 对于患有帕金森病的人来说,每年存在着显著的,可量化的痴呆风险.
- 在PDD风险估计中的异质性需要在未来的研究中进行标准化报告和年龄分层.
- 当前研究中的地理差距凸显了更广泛的研究纳入的必要性.
相关概念视频
Parkinson's Disease: Overview
512
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
512
Parkinson's Disease: Treatment
244
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
244
Dementia
110
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
110
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
Psychoneuroimmunology: Diabetes and Cancer
27
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
27


